\n\n\t| 17092434<\/td> | Cell Mol Immunol<\/td> | 2006<\/td> | Preparation and characterization of HLA-A*0201 tetramer loaded with IE-1316-324 antigenic peptide of human cytomegalovirus.<\/td>\n<\/tr>\n |
\n\t| 16275592<\/td> | Biol Blood Marrow Transplant<\/td> | 2005<\/td> | Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.<\/td>\n<\/tr>\n |
\n\t| 14550813<\/td> | Exp Hematol<\/td> | 2003<\/td> | A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation.<\/td>\n<\/tr>\n |
\n\t| 12634406<\/td> | J Virol<\/td> | 2003<\/td> | Use of transgenic HLA A*0201\/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response.<\/td>\n<\/tr>\n |
\n\t| 11930311<\/td> | J Infect Dis<\/td> | 2002<\/td> | Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype.<\/td>\n<\/tr>\n |
\n\t| 15619009<\/td> | Cell Mol Life Sci<\/td> | 2005<\/td> | Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.<\/td>\n<\/tr>\n |
\n\t| 17492595<\/td> | J Infect Dis<\/td> | 2007<\/td> | Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.<\/td>\n<\/tr>\n |
\n\t| 16388983<\/td> | J Clin Virol<\/td> | 2006<\/td> | Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.<\/td>\n<\/tr>\n |
\n\t| 14764694<\/td> | J Immunol<\/td> | 2004<\/td> | Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.<\/td>\n<\/tr>\n |
\n\t| 18982061<\/td> | PLoS One<\/td> | 2008<\/td> | Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.<\/td>\n<\/tr>\n |
\n\t| 18706443<\/td> | Immunol Lett<\/td> | 2008<\/td> | A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models.<\/td>\n<\/tr>\n |
\n\t| 14670917<\/td> | Blood<\/td> | 2004<\/td> | Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants.<\/td>\n<\/tr>\n |
\n\t| 22197248<\/td> | Antiviral Res<\/td> | 2012<\/td> | The development of Chinese specific human cytomegalovirus polyepitope recombinant vaccine.<\/td>\n<\/tr>\n |
\n\t| 23100361<\/td> | J Gen Virol<\/td> | 2013<\/td> | Suppression of CD8+ T-cell recognition in the immediate-early phase of human cytomegalovirus infection.<\/td>\n<\/tr>\n |
\n\t| 23267020<\/td> | J Immunol<\/td> | 2013<\/td> | CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex.<\/td>\n<\/tr>\n |
\n\t| 15597326<\/td> | Eur J Immunol<\/td> | 2005<\/td> | Contemporaneous fluctuations in T cell responses to persistent herpes virus infections.<\/td>\n<\/tr>\n |
\n\t| 23717207<\/td> | PLoS Pathog<\/td> | 2013<\/td> | Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.<\/td>\n<\/tr>\n |
\n\t| 23748502<\/td> | Nat Biotechnol<\/td> | 2013<\/td> | Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization.<\/td>\n<\/tr>\n |
\n\t| 24760079<\/td> | PLoS One<\/td> | 2014<\/td> | Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.<\/td>\n<\/tr>\n |
\n\t| 25108651<\/td> | Cytotherapy<\/td> | 2014<\/td> | Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease.<\/td>\n<\/tr>\n |
\n\t| 25339770<\/td> | J Virol<\/td> | 2015<\/td> | Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function.<\/td>\n<\/tr>\n |
\n\t| 26603974<\/td> | Am J Transplant<\/td> | 2016<\/td> | Virus-Specific CD8(+) T Cells Cross-Reactive to Donor-Alloantigen Are Transiently Present in the Circulation of Kidney Transplant Recipients Infected With CMV and\/or EBV.<\/td>\n<\/tr>\n |
\n\t| 26800118<\/td> | Clin Exp Immunol<\/td> | 2016<\/td> | Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.<\/td>\n<\/tr>\n |
\n\t| 26509579<\/td> | PLoS One<\/td> | 2015<\/td> | Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing.<\/td>\n<\/tr>\n |
\n\t| 26033882<\/td> | Cytometry A<\/td> | 2015<\/td> | Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05.<\/td>\n<\/tr>\n |
\n\t| 28818566<\/td> | Vaccine<\/td> | 2017<\/td> | A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells.<\/td>\n<\/tr>\n |
\n\t| 29666167<\/td> | J Exp Med<\/td> | 2018<\/td> | A flexible MHC class I multimer loading system for large-scale detection of antigen-specific T cells.<\/td>\n<\/tr>\n |
\n\t| 26314621<\/td> | Arthritis Rheumatol<\/td> | 2016<\/td> | Latent Cytomegalovirus Infection in Rheumatoid Arthritis and Increased Frequencies of Cytolytic LIR-1+CD8+ T Cells.<\/td>\n<\/tr>\n |
\n\t| 24512815<\/td> | J Immunol Methods<\/td> | 2014<\/td> | In vitro expansion of antigen-specific CD8(+) T cells distorts the T-cell repertoire.<\/td>\n<\/tr>\n |
\n\t| 31324690<\/td> | Sci Immunol<\/td> | 2019<\/td> | Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells.<\/td>\n<\/tr>\n |
\n\t| 31398327<\/td> | Cell<\/td> | 2019<\/td> | T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes.<\/td>\n<\/tr>\n |
\n\t| 32393905<\/td> | Nat Biotechnol<\/td> | 2020<\/td> | Massively parallel interrogation and mining of natively paired human TCRαβ repertoires.<\/td>\n<\/tr>\n |
\n\t| 33329532<\/td> | Front Immunol<\/td> | 2020<\/td> | Cytomegalovirus-Specific T Cell Epitope Recognition in Congenital Cytomegalovirus Mother-Infant Pairs.<\/td>\n<\/tr>\n |
\n\t| 33427749<\/td> | J Clin Invest<\/td> | 2021<\/td> | SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.<\/td>\n<\/tr>\n |
\n\t| 33853928<\/td> | Sci Immunol<\/td> | 2021<\/td> | SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8<sup>+<\/sup> T cell activation in COVID-19 patients.<\/td>\n<\/tr>\n |
\n\t| 36980230<\/td> | Cells<\/td> | 2023<\/td> | Persistent CD8 T Cell Marks Caused by the HCMV Infection in Seropositive Adults: Prevalence of HLA-E-Reactive CD8 T Cells.<\/td>\n<\/tr>\n |
\n\t| 36121440<\/td> | Blood Adv<\/td> | 2023<\/td> | Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing.<\/td>\n<\/tr>\n |
\n\t| 37586765<\/td> | J Immunother Cancer<\/td> | 2023<\/td> | TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.<\/td>\n<\/tr>\n |
\n\t| 35401538<\/td> | Front Immunol<\/td> | 2022<\/td> | Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals.<\/td>\n<\/tr>\n |
\n\t| 38053994<\/td> | Front Immunol<\/td> | 2023<\/td> | Overall avidity declines in TCR repertoires during latent CMV but not EBV infection.<\/td>\n<\/tr>\n |
\n\t| 38608022<\/td> | Sci Adv<\/td> | 2024<\/td> | Simultaneous analysis of pMHC binding and reactivity unveils virus-specific CD8 T cell immunity to a concise epitope set.<\/td>\n<\/tr>\n |
\n\t| 37133356<\/td> | Elife<\/td> | 2023<\/td> | Improved T cell receptor antigen pairing through data-driven filtering of sequencing information from single cells.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\r\n\r\n\r\n <\/p>\r\n\r\n\r\n\r\n <\/p>\r\n Views: 13<\/p>","protected":false},"excerpt":{"rendered":" \u9776\u70b9\u8bf4\u660e \u86cb\u767d\u590d\u5408\u7269\uff1aIE1 (316-324) VLEETSVML HLA-A*02:01 IE1\uff08Imme…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"default","_kad_post_title":"default","_kad_post_layout":"default","_kad_post_sidebar_id":"","_kad_post_content_style":"default","_kad_post_vertical_padding":"default","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"class_list":["post-749","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/pages\/749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=749"}],"version-history":[{"count":9,"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/pages\/749\/revisions"}],"predecessor-version":[{"id":1687,"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=\/wp\/v2\/pages\/749\/revisions\/1687"}],"wp:attachment":[{"href":"https:\/\/www.guixiong.com.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} |
![\"\"](\"https:\/\/www.guixiong.com.cn\/wp-content\/uploads\/2025\/07\/image-3.png\")
<\/figure>\r\n<\/div>\r\n\r\n\r\n\r\n![\"\"](\"https:\/\/www.guixiong.com.cn\/wp-content\/uploads\/2025\/07\/image-4.png\")
<\/figure>\r\n<\/div>\r\n<\/div>\r\n\r\n\r\n\r\n